SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/28/20 Petmed Express Inc. 8-K:2,9 10/26/20 12:255K RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 25K 2: EX-99.1 Miscellaneous Exhibit HTML 45K 8: R1 Document And Entity Information HTML 46K 10: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- pets20201028_8k_htm XML 13K 9: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.DEF XBRL Definitions -- pets-20201026_def XML 37K 5: EX-101.LAB XBRL Labels -- pets-20201026_lab XML 48K 6: EX-101.PRE XBRL Presentations -- pets-20201026_pre XML 36K 3: EX-101.SCH XBRL Schema -- pets-20201026 XSD 14K 11: JSON XBRL Instance as JSON Data -- MetaLinks 12± 19K 12: ZIP XBRL Zipped Folder -- 0001437749-20-021782-xbrl Zip 20K
i PetMed Express, Inc.
(Exact name of registrant as specified in its charter) |
i Florida
|
i 65-0680967
|
|
(State or other jurisdiction
of incorporation) |
(Commission
File Number) |
(I.R.S. Employer
Identification No.) |
(Address of principal executive offices) (Zip Code)
|
( i 561) i 526-4444
|
(Registrant’s telephone number, including area code)
|
Not Applicable
|
(Former name or former address, if changed since last report)
|
i ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
||||
|
|
||||
i ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
||||
|
|
||||
i ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
||||
|
|
||||
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
Securities registered pursuant to Section 12(b) of the Act: |
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
i Common Stock, par value $.001 per share
|
i PETS
|
i NASDAQ Global Select Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
|
(d)
|
Exhibits.
|
|
|
|
|
|
104 – Cover Page Interactive Data File (formatted as Inline XBRL).
|
Exhibit No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
PetMed Express, Inc. conference call transcript dated October 26, 2020.
|
|
|
PETMED EXPRESS, INC.
|
|
|
|
|
|
By:
|
|
|
Name:
|
|
|
Title:
|
Chief Financial Officer
|
|
|
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 10/28/20 | |||
For Period end: | 10/26/20 | 8-K | ||
9/30/20 | 10-Q | |||
List all Filings |